Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mitsubishi Chemical GroupFRA:M3C +1.27%74 Debt-to-EBITDA is 2.40 as of Jun. 2026, which is 48% below its 10-year median of 4.62. GuruFocus rates FRA:M3C with a GF Score™ of 74/100 and a GF Value™ of €4.45 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 1,239 Chemicals companies, Mitsubishi Chemical Group ranks worse than 75.3% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Mitsubishi Chemical Group's Debt-to-EBITDA or its related term are showing as below:
FRA:M3C'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.16 Med: 4.62 Max: 7.84
Current: 4.97
During the past 13 years, the highest Debt-to-EBITDA Ratio of Mitsubishi Chemical Group was 7.84. The lowest was 3.16. And the median was 4.62.
FRA:M3C's Debt-to-EBITDA is ranked worse than 75.3% of 1239
companies
in the Chemicals industry
Industry Median: 2.15
vs FRA:M3C: 4.97
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Mitsubishi Chemical Group Debt-to-EBITDA Related Terms
Mitsubishi Chemical Group Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3C vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Mitsubishi Chemical Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mitsubishi Chemical Group Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Mitsubishi Chemical Group's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Mitsubishi Chemical Group's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Mitsubishi Chemical Group (FRA:M3C) has a Debt-to-EBITDA of 2.40 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Mitsubishi Chemical Group. This is 48% below median its historical median of 4.62. Over the past decade, Mitsubishi Chemical Group's Debt-to-EBITDA has ranged from 3.16 to 7.84. According to the industry distribution chart, Mitsubishi Chemical Group ranks #933 out of 1239 companies in the Chemicals industry, placing it in the top 75.3%.
Is Mitsubishi Chemical Group's Debt-to-EBITDA too high?
Mitsubishi Chemical Group's current Debt-to-EBITDA of 2.40 is 48% below median its 10-year median of 4.62. Over the past 10 years, this metric has ranged from a low of 3.16 to a high of 7.84. The Chemicals industry median Debt-to-EBITDA is 2.15. Mitsubishi Chemical Group's value of 2.40 is 11.6% above this industry median. Based on the distribution chart, Mitsubishi Chemical Group ranks #933 out of 1239 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Mitsubishi Chemical Group has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mitsubishi Chemical Group's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Mitsubishi Chemical Group ranks #933 out of 1239 companies for Debt-to-EBITDA. This places Mitsubishi Chemical Group in the lower half of its industry. The industry median Debt-to-EBITDA is 2.15. Mitsubishi Chemical Group's value of 2.40 is 11.6% above this benchmark. Historically, Mitsubishi Chemical Group's own Debt-to-EBITDA has ranged from 3.16 to 7.84 over the past decade. While the company's 10-year median is 4.62 vs. the industry median of 2.15, Mitsubishi Chemical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.15, based on 1,239 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mitsubishi Chemical Group's current Debt-to-EBITDA of 2.40 is 11.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Mitsubishi Chemical Group. For the Chemicals industry, the median Debt-to-EBITDA is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mitsubishi Chemical Group's current Debt-to-EBITDA is 2.40, which is 48% below median its own 10-year median of 4.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mitsubishi Chemical Group stock overvalued right now?
Based on GuruFocus' analysis, Mitsubishi Chemical Group (FRA:M3C) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.45, compared to a current price of €6.34 — trading 42.5% above its estimated fair value. The current Debt-to-EBITDA is 2.40, which is 48% below median its 10-year median of 4.62 and 11.6% above the Chemicals industry median of 2.15. Mitsubishi Chemical Group's overall GF Score™ is 74/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Mitsubishi Chemical Group (FRA:M3C), the current Debt-to-EBITDA is 2.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mitsubishi Chemical Group (FRA:M3C) Overvalued in 2026?
Based on GuruFocus' analysis, Mitsubishi Chemical Group stock appears to be overvalued.
The current stock price of €6.34 is trading 42.5% above its estimated GF Value™ of €4.45.
GuruFocus considers Mitsubishi Chemical Group to be Significantly Overvalued.
Key valuation signals for FRA:M3C:
Debt-to-EBITDA: 2.40 (48% below median its 10-year median of 4.62)
GF Value™: €4.45 vs. price of €6.34 (42.5% above fair value)
Industry Position: 11.6% above the Chemicals median (#933 of 1239)
No single metric tells the full story. See the FRA:M3C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mitsubishi Chemical Group Corp is a holding company which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into five segments. The Basic Materials & Polymers segment covers petrochemical substrates, polyolefins, basic chemicals, sustainable polymers, engineering plastics, and carbon. The Industrial Gas segment focuses on industrial gases. The MMA & Derivatives segment includes MMA, PMMA, coatings, additives, and fine chemicals. The Pharmacy segment is engaged in medicines, and the Specialty Materials segment handles advanced films and polymers, advanced solutions, and advanced composites. The Others segment includes businesses such as engineering, transportation, and warehousing. It generates the majority of its revenue from the Industrial gas segment.
74GF Score
Get the complete analysis for FRA:M3C
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3C has been successfully added to your 
